BioCatalyst

KOD — Kodiak Sciences Inc. catalysts

1 verified catalyst event(s) for Kodiak Sciences Inc. (ticker KOD). Each is linked to its official source. Verified as of 2026-06-22.

Next verified catalyst

2026-08-01 — A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer · official source ↗

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-08 (month)
in 1mo
ESTIMATED
 READOUT
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafus
Phase 3 · Wet Age-related Macular Degeneration
 KOD Kodiak Sciences Inc. Tarcocimab tedromer, Tabirafusp tedromer ClinicalTrials.gov ↗
✓ Source-checked 2026-06-22
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.